Exact Mass: 448.34132339999996

Exact Mass Matches: 448.34132339999996

Found 29 metabolites which its exact mass value is equals to given mass value 448.34132339999996, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Arachidonoylcarnitine

(3R)-3-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyloxy]-4-(trimethylazaniumyl)butanoate

C27H46NO4 (448.34266560000003)


Arachidonyl carnitine is an acylcarnitine. Numerous disorders have been described that lead to disturbances in energy production and in intermediary metabolism in the organism which are characterized by the production and excretion of unusual acylcarnitines. A mutation in the gene coding for carnitine-acylcarnitine translocase or the OCTN2 transporter aetiologically causes a carnitine deficiency that results in poor intestinal absorption of dietary L-carnitine, its impaired reabsorption by the kidney and, consequently, in increased urinary loss of L-carnitine. Determination of the qualitative pattern of acylcarnitines can be of diagnostic and therapeutic importance. The betaine structure of carnitine requires special analytical procedures for recording. The ionic nature of L-carnitine causes a high water solubility which decreases with increasing chain length of the ester group in the acylcarnitines. Therefore, the distribution of L-carnitine and acylcarnitines in various organs is defined by their function and their physico-chemical properties as well. High performance liquid chromatography (HPLC) permits screening for free and total carnitine, as well as complete quantitative acylcarnitine determination, including the long-chain acylcarnitine profile. (PMID: 17508264, Monatshefte fuer Chemie (2005), 136(8), 1279-1291., Int J Mass Spectrom. 1999;188:39-52.) [HMDB] Arachidonyl carnitine is an acylcarnitine. Numerous disorders have been described that lead to disturbances in energy production and in intermediary metabolism in the organism which are characterized by the production and excretion of unusual acylcarnitines. A mutation in the gene coding for carnitine-acylcarnitine translocase or the OCTN2 transporter aetiologically causes a carnitine deficiency that results in poor intestinal absorption of dietary L-carnitine, its impaired reabsorption by the kidney and, consequently, in increased urinary loss of L-carnitine. Determination of the qualitative pattern of acylcarnitines can be of diagnostic and therapeutic importance. The betaine structure of carnitine requires special analytical procedures for recording. The ionic nature of L-carnitine causes a high water solubility which decreases with increasing chain length of the ester group in the acylcarnitines. Therefore, the distribution of L-carnitine and acylcarnitines in various organs is defined by their function and their physico-chemical properties as well. High performance liquid chromatography (HPLC) permits screening for free and total carnitine, as well as complete quantitative acylcarnitine determination, including the long-chain acylcarnitine profile. (PMID: 17508264, Monatshefte fuer Chemie (2005), 136(8), 1279-1291., Int J Mass Spectrom. 1999;188:39-52.).

   
   

(2R)-3-(hexadecyloxy)-2-hydroxypropyl beta-D-lyxofuranoside|sarcoglycoside C

(2R)-3-(hexadecyloxy)-2-hydroxypropyl beta-D-lyxofuranoside|sarcoglycoside C

C24H48O7 (448.33998579999997)


   
   

(2R)-1-hydroxy-3-hexadecyloxy-propyl beta-D-arabinopyranoside

(2R)-1-hydroxy-3-hexadecyloxy-propyl beta-D-arabinopyranoside

C24H48O7 (448.33998579999997)


   
   

2-(3,7,11,15,19-Pentamethyl-2,6,10,14,18-eicosapentaenyl)-1,4-benzoquinone|2-<(2E,6E,10E,14E,18E)-3,7,11,15,19-pentamethylicosa-2,6,10,14,18-pentaenyl>-1,4-benzoquinone|2-Pentaprenylbenzochinon|Quinone---2-Pentaprenyl-1,4-benzenediol

2-(3,7,11,15,19-Pentamethyl-2,6,10,14,18-eicosapentaenyl)-1,4-benzoquinone|2-<(2E,6E,10E,14E,18E)-3,7,11,15,19-pentamethylicosa-2,6,10,14,18-pentaenyl>-1,4-benzoquinone|2-Pentaprenylbenzochinon|Quinone---2-Pentaprenyl-1,4-benzenediol

C31H44O2 (448.3341124)


   

(5Z,7E)-(1S,3R,24R)-25-fluoro-24-methyl-9,10-seco-5,7,10(19)-cholestatrien-1,3,24-triol

(24R)-25-fluoro-1α,24-dihydroxy-24-methylvitamin D3 / (24R)-25-fluoro-1α,24-dihydroxy-24-methylcholecalciferol

C28H45FO3 (448.3352552)


   

11α-(fluoromethyl)-1α,25-dihydroxyvitamin D3 / 11α-(fluoromethyl)-1α,25-dihydroxycholecalciferol

11α-(fluoromethyl)-1α,25-dihydroxyvitamin D3 / 11α-(fluoromethyl)-1α,25-dihydroxycholecalciferol

C28H45FO3 (448.3352552)


   

11alpha-(fluoromethyl)-1alpha,25-dihydroxyvitamin D3

(5Z,7E)-(1S,3R,11S)-11-(fluoromethyl)-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol

C28H45O3F (448.3352552)


   

4-(TRANS-4-PENTYLCYCLOHEXYL)-4-(TRANS-4-PROPYLCYCLOHEXYL)-2-FLUOROBIPHENYL

4-(TRANS-4-PENTYLCYCLOHEXYL)-4-(TRANS-4-PROPYLCYCLOHEXYL)-2-FLUOROBIPHENYL

C32H45F (448.3505102)


   
   

trans,trans-2-Fluor-4-(4-pentylcyclohexyl)-4-(4-propyl-cyclohexyl)-1,1-biphenyl

trans,trans-2-Fluor-4-(4-pentylcyclohexyl)-4-(4-propyl-cyclohexyl)-1,1-biphenyl

C32H45F (448.3505102)


   

4-Heptylphenyl 4-(trans-4-pentylcyclohexyl)benzoate

4-Heptylphenyl 4-(trans-4-pentylcyclohexyl)benzoate

C31H44O2 (448.3341124)


   

4-Pentylphenyl-4-Trans-HeptylcyclohexylBenzoate

4-Pentylphenyl-4-Trans-HeptylcyclohexylBenzoate

C31H44O2 (448.3341124)


   
   

[3-carboxy-2-[(8E,11E,14E,17E)-icosa-8,11,14,17-tetraenoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(8E,11E,14E,17E)-icosa-8,11,14,17-tetraenoyl]oxypropyl]-trimethylazanium

C27H46NO4+ (448.34266560000003)


   

[3-carboxy-2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxypropyl]-trimethylazanium

C27H46NO4+ (448.34266560000003)


   

[(7E,10E,13E,16E)-2-(carboxymethyl)-2-hydroxy-3-oxodocosa-7,10,13,16-tetraenyl]-trimethylazanium

[(7E,10E,13E,16E)-2-(carboxymethyl)-2-hydroxy-3-oxodocosa-7,10,13,16-tetraenyl]-trimethylazanium

C27H46NO4+ (448.34266560000003)


   

[3-carboxy-2-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyl]oxypropyl]-trimethylazanium

C27H46NO4+ (448.34266560000003)


   
   

NA-Tryptamine 20:3(8Z,11Z,14Z)

NA-Tryptamine 20:3(8Z,11Z,14Z)

C30H44N2O (448.3453454)


   

3-[(3e,7e,11e,15e)-19-(furan-3-yl)-4,8,12,16-tetramethylnonadeca-3,7,11,15-tetraen-1-yl]furan

3-[(3e,7e,11e,15e)-19-(furan-3-yl)-4,8,12,16-tetramethylnonadeca-3,7,11,15-tetraen-1-yl]furan

C31H44O2 (448.3341124)


   

3-[19-(furan-3-yl)-4,8,12,16-tetramethylnonadeca-3,7,11,15-tetraen-1-yl]furan

3-[19-(furan-3-yl)-4,8,12,16-tetramethylnonadeca-3,7,11,15-tetraen-1-yl]furan

C31H44O2 (448.3341124)


   

(2s,3s,4r,5r)-2-{[(2r)-1-(hexadecyloxy)-3-hydroxypropan-2-yl]oxy}oxane-3,4,5-triol

(2s,3s,4r,5r)-2-{[(2r)-1-(hexadecyloxy)-3-hydroxypropan-2-yl]oxy}oxane-3,4,5-triol

C24H48O7 (448.33998579999997)


   

(1s,2r,6e,9z,12e,18s,19r,20r,27e)-16,22-diazapentacyclo[14.14.1.1³,²⁰.0¹,¹⁹.0²,²²]dotriaconta-3(32),6,9,12,27-pentaen-18-ol

(1s,2r,6e,9z,12e,18s,19r,20r,27e)-16,22-diazapentacyclo[14.14.1.1³,²⁰.0¹,¹⁹.0²,²²]dotriaconta-3(32),6,9,12,27-pentaen-18-ol

C30H44N2O (448.3453454)


   

(1s,2r,6e,9z,12e,18s,19r,27e)-16,22-diazapentacyclo[14.14.1.1³,²⁰.0¹,¹⁹.0²,²²]dotriaconta-3(32),6,9,12,27-pentaen-18-ol

(1s,2r,6e,9z,12e,18s,19r,27e)-16,22-diazapentacyclo[14.14.1.1³,²⁰.0¹,¹⁹.0²,²²]dotriaconta-3(32),6,9,12,27-pentaen-18-ol

C30H44N2O (448.3453454)


   

2-{[1-(hexadecyloxy)-3-hydroxypropan-2-yl]oxy}oxane-3,4,5-triol

2-{[1-(hexadecyloxy)-3-hydroxypropan-2-yl]oxy}oxane-3,4,5-triol

C24H48O7 (448.33998579999997)